Anna Chu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Venous Thromboembolism

Antiplatelet Therapy

Clinical Practice

Cardiovascular Disease

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Amy Ying Xin Yu, Peter C Austin, Cynthia A Jackevicius, Anna Chu, Jessalyn K Holodinsky, Michael D Hill, Noreen Kamal, Mukesh Kumar, Douglas S Lee, Manav V Vyas, Raed A Joundi, Nadia A Khan, Moira K Kapral, Candace D McNaughton
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022. Journal of the American Heart Association 13 (8) (2024)
Amy Ying Xin Yu, Peter C Austin, Cynthia A Jackevicius, Anna Chu, Jessalyn K Holodinsky, Michael D Hill, Noreen Kamal, Mukesh Kumar, Douglas S Lee, Manav V Vyas, Raed A Joundi, Nadia A Khan, Moira K Kapral, Candace D McNaughton
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022. Journal of the American Heart Association 13 (8) (2024)
Amy Ying Xin Yu, Peter C Austin, Cynthia A Jackevicius, Anna Chu, Jessalyn K Holodinsky, Michael D Hill, Noreen Kamal, Mukesh Kumar, Douglas S Lee, Manav V Vyas, Raed A Joundi, Nadia A Khan, Moira K Kapral, Candace D McNaughton
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022. Journal of the American Heart Association (2024)
Amy Ying Xin Yu, Peter C Austin, Cynthia A Jackevicius, Anna Chu, Jessalyn K Holodinsky, Michael D Hill, Noreen Kamal, Mukesh Kumar, Douglas S Lee, Manav V Vyas, Raed A Joundi, Nadia A Khan, Moira K Kapral, Candace D McNaughton
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022. Journal of the American Heart Association 13 (8) (2024)
Amy Ying Xin Yu, Peter C Austin, Cynthia A Jackevicius, Anna Chu, Jessalyn K Holodinsky, Michael D Hill, Noreen Kamal, Mukesh Kumar, Douglas S Lee, Manav V Vyas, Raed A Joundi, Nadia A Khan, Moira K Kapral, Candace D McNaughton
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022. Journal of the American Heart Association 13 (8) (2024)
Amy Ying Xin Yu, Kara A Nerenberg, Christina Diong, Jiming Fang, Anna Chu, Moira K Kapral, Jodi D Edwards, Sonia R Dancey, Peter C Austin, Nathalie Auger
Maternal Health Outcomes After Pregnancy-Associated Stroke: A Population-Based Study With 19 Years of Follow-Up. Stroke 54 (2) (2023)
Amy Ying Xin Yu, Kara A Nerenberg, Christina Diong, Jiming Fang, Anna Chu, Moira K Kapral, Jodi D Edwards, Sonia R Dancey, Peter C Austin, Nathalie Auger
Maternal Health Outcomes After Pregnancy-Associated Stroke: A Population-Based Study With 19 Years of Follow-Up. Stroke 54 (2) (2023)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)
Manav V Vyas, Amy Ying Xin Yu, Anna Chu, Bing Yu, Hibo Rijal, Jiming Fang, Peter C Austin, Moira K Kapral
Immigration Status and Sex Differences in Primary Cardiovascular Disease Prevention: A Retrospective Study of 5 Million Adults. Journal of the American Heart Association 10 (22) (2021)